DrugChatter Featured Questions
DrugChatter recently launched as an experimental AI chat-based business intelligence tool. Here’s some of the more interesting questions it’s been […]
DrugChatter.com: AI Chat for Biopharmaceutical Drug Insights
Introducing DrugChatter.com: Empowering Access to Biopharmaceutical Drug Insights through AI Chat We are pleased to introduce DrugChatter.com, a groundbreaking platform
DrugChatter.com: AI Chat for Biopharmaceutical Drug Insights Read Post »
NPR and DrugPatentWatch – Can drug injector pens be swapped?
On NPR’s All Things Considered, Sydney Lupkin asked DrugPatentWatch if drug patents could be used to identify injector pens which
NPR and DrugPatentWatch – Can drug injector pens be swapped? Read Post »
Utilizing 505(b)(2) Regulatory Pathway for New Drug Applications: An Overview on the Advanced Formulation Approach and Challenges
In the ever-evolving landscape of pharmaceutical development, the 505(b)(2) regulatory pathway has emerged as a game-changer for drug manufacturers seeking
Social Return on Investment
This is a guest post by Oleksandr Topachevskyi at Digital Health Outcomes. Oleksandr may be contacted at sales@digitalho.com Commercial, nonprofit,
CDCDB: A large and continuously updated drug combination database
This article was originally published by Guy Shtar, Louise Azulay, Omer Nizri, Lior Rokach & Bracha Shapira in Scientific Data
CDCDB: A large and continuously updated drug combination database Read Post »
DrugPatentWatch named “Best of the Web” by Genetic Engineering News
DrugPatentWatch has been named to Genetic Engineering News‘ Best of the Web list. The review by Genetic Engineering News profile
DrugPatentWatch named “Best of the Web” by Genetic Engineering News Read Post »
The value of method of use patent claims in protecting your therapeutic assets
This is a guest post by Ray Miller and Megan E. Bowers, Ph.D. at DLA Piper. Ray may be contacted
The value of method of use patent claims in protecting your therapeutic assets Read Post »
DrugPatentWatch Week in Review
FEATURED ARTICLE Branded Generics Promise Profits for Drugmakers, Peace of Mind for Patients Developing nations offer welcoming and growing markets
